FGI-AGOMELATINE agomelatine (as agomelatine-citric acid) 25 mg tablet blister pack

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

agomelatine-citric acid, Quantity: 44.739 mg (Equivalent: agomelatine, Qty 25 mg)

Tilgængelig fra:

Helix Pharmaceuticals Pty Ltd

Lægemiddelform:

Tablet, film coated

Sammensætning:

Excipient Ingredients: titanium dioxide; iron oxide yellow; colloidal anhydrous silica; purified talc; povidone; sodium stearylfumarate; stearic acid; silicified microcrystalline cellulose; crospovidone; hypromellose; mannitol; macrogol 6000; magnesium stearate

Indgivelsesvej:

Oral

Enheder i pakken:

28 tablets

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

Treatment of major depressive disorder (MDD) in adults including prevention of relapse.

Produkt oversigt:

Visual Identification: Yellow, oblong, biconvex film-coated tablet; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Registered